Skip to main content

Month: March 2026

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results

Record full-year total revenue and AVISE® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume growth CARLSBAD, Calif., March 10, 2026 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today reported financial results for the fourth quarter and full year ended December 31, 2025, and recent business highlights.         Three Months Ended December 31,   Year Ended December 31,  2025   2025(in thousands, except ASP data)  Revenue $ 16,631     $ 66,575  Gross margin   55.4 %     58.3 %Operating expenses $ 14,181     $ 52,869  Loss from operations $ (4,975 )   $ (14,070 )Net loss $ (4,673 )   $ (19,951 )Adjusted EBITDA $ (3,670 )   $ (9,794 )Cash, cash equivalents and restricted cash $32,420Trailing-twelve-month...

Continue reading

Core Molding Technologies Reports Full Year and Fourth Quarter 2025 Results

Fourth Quarter Total Sales Up 19.5% Driven by Elevated Tooling Revenue; Full Year Business Wins of $63 Million Support Multi-Year Revenue Expansion COLUMBUS, Ohio, March 10, 2026 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today reported financial and operating results for the fiscal periods ended December 31, 2025. David Duvall, the Company’s President and Chief Executive Officer, said, “Fiscal 2025 was intensely focused on our Invest For Growth Must Win Battle – and we delivered as stated. We won $63 million in business,...

Continue reading

ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a company update. Company HighlightsThe IMG-007 Phase 2b ADAPTIVE trial in adults with moderate-to-severe atopic dermatitis (AD) is ongoing at North American sites; the study began enrolling in mid-2025 with topline data expected in 2027. A recent blinded safety review showed a favorable emerging tolerability profile consistent with previous IMG-007 patient experience. The Company has submitted a protocol amendment intended to expand the number and exposure range of dosing regimens being evaluated, characterize the role of loading doses, evaluate patient-friendly dosing intervals, and understand the effect of short-...

Continue reading

Global Indemnity Group, LLC Reports Full Year 2025 Financial Results

Accident Year 2025 Underwriting Profitability Improves Across Every Quarter; Current Accident Year Combined Ratio Excluding California Wildfires Reaches 92.2% WILMINGTON, Del., March 10, 2026 (GLOBE NEWSWIRE) — Global Indemnity Group, LLC (Nasdaq: GBLI) (the “Company”) today reported financial results for the twelve months ended December 31, 2025. The year was defined by two distinct narratives: a significant California Wildfire loss event in January 2025, and a steady, quarter-by-quarter improvement in underlying underwriting performance that continued through year end. Net losses from the California Wildfires totaled $15.7 million pre-tax ($12.0 million after-tax). Excluding this event, the Company’s current accident year combined ratio improved in each successive period throughout 2025, reaching 92.2% for the...

Continue reading

LyondellBasell to address 2026 J.P. Morgan Industrials Conference

HOUSTON and LONDON, March 10, 2026 (GLOBE NEWSWIRE) — LyondellBasell (NYSE: LYB), a leader in the global chemical industry, today announced that Agustin Izquierdo, executive vice president and chief financial officer, will participate in a fireside chat at the 2026 J.P. Morgan Industrials Conference in Washington, D.C., on Tuesday, March 17, 2026, at 3:40 p.m. EDT.Webcast and Presentation Slides AccessA live webcast can be accessed at the time of the event at https://investors.lyondellbasell.com/events-and-presentations/default.aspx. A replay of the event will be available at the same link within 24 hours following the webcast. About LyondellBasell  We are LyondellBasell (NYSE: LYB) – a leader in the global chemical industry creating solutions for everyday sustainable living. Through advanced technology and focused investments,...

Continue reading

FBS Global Limited Engages Crescendo Communications for Investor Relations Services

Singapore, March 10, 2026 (GLOBE NEWSWIRE) — FBS Global Limited (Nasdaq: FBGL) (“FBS” or the “Company”), a green building contractor and interior fit-out specialist with more than 30 years of operating history, today announced that it has engaged Crescendo Communications, LLC, a New York-based strategic advisory firm, to provide investor relations services and support the Company’s capital markets communications strategy. Under the engagement, Crescendo Communications will work with FBS Global’s management team to enhance communication with institutional investors, research analysts and the broader investment community. The engagement will focus on strengthening market visibility, supporting investor outreach initiatives and assisting with strategic messaging around the Company’s operational execution and long-term growth objectives. Kelvin...

Continue reading

Worthington Enterprises Schedules Fiscal Third Quarter 2026 Earnings Call for March 25

COLUMBUS, Ohio, March 10, 2026 (GLOBE NEWSWIRE) — Worthington Enterprises Inc. (NYSE: WOR) will hold its quarterly earnings conference call Wednesday, March 25 at 8:30 a.m. ET. The company will discuss its fiscal third quarter results, which will be released after the market closes Tuesday, March 24. Please click here to register for the March 25 live audio webcast or visit IR.worthingtonenterprises.com. For those unable to listen live, a replay will be available in the Investors section of the company’s website approximately two hours after the completion of the call and will be archived for one year.   LIVE CONFERENCE CALL DETAILSDate:  Wednesday, March 25, 2026Webcast Link: https://events.q4inc.com/attendee/999794906Starting Time:  8:30 a.m. ETConference ID: 1777337Domestic Participants:  888-330-3567   About...

Continue reading

Lead Real Estate Co., Ltd Announces Delivery of EXCELSIOR NAKAMEGURO in Tokyo

TOKYO, March 10, 2026 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or the “Company”), a Japanese real estate developer of residential properties across Tokyo, Kanagawa Prefecture and Sapporo, today announced that it executed a sales contract for its income-producing condominium property, EXCELSIOR NAKAMEGURO, on February 17, 2026. The Company completed the delivery of the property on February 27, 2026. EXCELSIOR NAKAMEGURO is a 10-unit reinforced concrete condominium located in Kamimeguro, Meguro, Tokyo. The property consists of three floors above ground, with a building area of approximately 4,667 square feet and a land area of approximately 2,805 square feet.Actual Completed ExteriorActual Completed Interior Mr. Eiji Nagahara, Chief Executive Officer of Lead Real Estate Co., Ltd, commented: “The sale...

Continue reading

Rackspace and Uniphore Announce Strategic Partnership to Define a New Category of Infrastructure-to-Agents Architecture Accelerating Enterprise AI Adoption

SAN ANTONIO, March 10, 2026 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading hybrid multicloud and AI solutions company, today announced a strategic partnership with Uniphore, the Business AI leader backed by NVIDIA and AMD, to deliver the industry’s first Infrastructure-to-Agents architecture, offered as an outcomes-based service. The partnership reflects a shared ambition to unlock $100 million in enterprise AI deployments as customers move from AI experimentation to production at scale, without sacrificing governance, security, or control. This is especially relevant for regulated industries where choice, security and sovereignty are non-negotiable requirements. Operationalizing AI in production remains a challenge due to the complexity of choices across the stack. By integrating Uniphore’s Business AI...

Continue reading

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Recent Highlights:Fourth quarter revenue of $2.4 million, a 4% increase compared to the prior-year quarter and 9% increase sequentially. 208% increase in U.S. console sales in Q4 versus prior year quarter. Heart Failure revenue increased 48% and Pediatrics increased 16% year-over-year in Q4. Gross margin of 68.2% in Q4, compared to 58.4% in the prior-year quarter. Closed a $5.0 million private placement and warrant inducement transaction in January 2026, strengthening the Company’s capital position. Appointed Carisa Schultz as Chief...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.